Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | P4HB | P07237 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.70 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.70 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.63 |
| ▸ | XDH | P47989 | 1/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.58 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.58 |
| ▸ | TUBB | P07437 | 1/20 | 0.58 |
| ▸ | YES1 | P07947 | 1/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Liquiritin SCHEMBL13906116 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL13931703 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL26113334 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL29536850 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL24209243 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL24835038 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL29351306 | 0.94 | TRPA1 (0.89) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL10926327 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL27939664 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL31504735 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968755-B2 | Topical base and active agent-containing compositions, and methods for improving and treating skin | SCHLESSINGER JOEL (US) | 2015-03-03 | — | — | US | claimed |
| US-20130177618-A1 | TOPICAL BASE AND ACTIVE AGENT-CONTAINING COMPOSITIONS, AND METHODS FOR IMPROVING AND TREATING SKIN | SCHLESSINGER JOEL (US) | 2013-07-11 | — | — | US | claimed |
| US-8968755-B2 | Topical base and active agent-containing compositions, and methods for improving and treating skin | SCHLESSINGER JOEL (US) | 2015-03-03 | — | — | US | disclosed |
| US-20130177618-A1 | TOPICAL BASE AND ACTIVE AGENT-CONTAINING COMPOSITIONS, AND METHODS FOR IMPROVING AND TREATING SKIN | SCHLESSINGER JOEL (US) | 2013-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130177618-A1 | TOPICAL BASE AND ACTIVE AGENT-CONTAINING COMPOSITIONS, AND METHODS FOR IMPROVING AND TREATING SKIN | FANCI, FANCF, FANCD2 | TRPA1 991/4885P4HB 4164/4885TRPV1 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.